Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in Molecular PathologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and management.Am J Hematol. 2012; 87: 511-519
- Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up.Mod Pathol. 2022; 35: 306-331
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms.Blood. 2016; 127: 2375-2390
- Pathobiology of peripheral T-cell lymphomas.Hematol Am Soc Hematol Educ Program. 2006; : 317-322
- WHO classification of tumours of haematopoietic and lymphoid tissues.in: Campo E. Harris N.L. Jaffe E.S. WHO classification of tumors. 4th edition. World Health Organization, Lyon, France2017: 190-198
- Molecular insights into pathogenesis and targeted therapy of peripheral T cell lymphoma.Exp Hematol Oncol. 2020; 9: 30
- High Incidence of Clonal CD8+ T-cell Proliferation in Non-malignant Conditions May Reduce the Significance of T-cell Clonality Assay for Differential Diagnosis in Oncohematology.Clin Lymphoma Myeloma Leuk. 2020; 20: 203-208
- T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides.J Am Acad Dermatol. 2015; 73: 228-236.e2
- International T-Cell Lymphoma Project. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.J Clin Oncol. 2008; 26: 4124-4130
- GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features.Blood. 2014; 123: 3007-3015
- Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma.Blood. 2014; 123: 2915-2923
- Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry.Blood. 2019; 134: 2159-2170
- Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.Blood. 2019; 133: 1664-1676
- CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS).Haematologica. 2021; 106: 2918-2926
- Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling.Leukemia. 2019; 33: 2867-2883
- Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin.Haematologica. 2017; 102: e148-e151
- Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.Blood. 2012; 120: 1466-1469
- Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified.Mod Pathol. 2020; 33: 179-187
- Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified.Haematologica. 2018; 103: 679-687
- Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified.Nat Commun. 2021; 12: 3705
- Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas.Proc Natl Acad Sci U S A. 2017; 114: 764-769
- Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas.Blood. 2012; 120: 2280-2289
- Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets.Haematologica. 2015; 100: e361-e364
- Genomics of Peripheral T-Cell Lymphoma and Its Implications for Personalized Medicine.Front Oncol. 2019; 10: 898
- A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma.Nat Genet. 2014; 46: 371-375
- Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.Nat Genet. 2014; 46: 171-175
- Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic Features.Am J Surg Pathol. 2016; 40: 335-341
- Clinicopathologic Analysis of Angioimmunoblastic T-cell Lymphoma With or Without RHOA G17V Mutation Using Formalin-fixed Paraffin-embedded Sections.Am J Surg Pathol. 2016; 40: 1041-1050
- Mutational heterogeneity of angioimmunoblastic T-cell lymphoma indicates distinct lymphomagenic pathways.Blood Cancer J. 2018; 8: 6
- The pathological features of angioimmunoblastic T-cell lymphomas with IDH2R172 mutations.Mod Pathol. 2019; 32: 1123-1134
- Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms.Blood Adv. 2020; 4: 2261-2271
- TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis.Cancer Cell. 2011; 20: 25-38
- Identification of cell-type-specific mutations in nodal T-cell lymphomas.Blood Cancer J. 2017; 7: e516
- Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma.Haematologica. 2016; 101: 757-763
- Recurrent activating mutations of CD28 in peripheral T-cell lymphomas.Leukemia. 2016; 30: 1062-1070
- Aggressive T-cell lymphomas: 2021 Updates on diagnosis, risk stratification and management.Am J Hematol. 2021; 96: 1027-1046
- FER and FES tyrosine kinase fusions in follicular T-cell lymphoma.Blood. 2020; 135: 584-588
- Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma.Leukemia. 2006; 20: 313-318
- Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas.Am J Surg Pathol. 2009; 33: 682-690
- ITK/SYK translocation in angioimmunoblastic T-cell lymphoma.Am J Surg Pathol. 2013; 37: 1456-1457
- Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.Blood. 2016; 128: 1490-1502
- Anaplastic large cell lymphoma: changes in the World Health Organization classification and perspectives for targeted therapy.Haematologica. 2009; 94: 897-900
- Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.Science. 1994; 263: 1281-1284
- Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target.Blood. 2017; 129: 823-831
- The anaplastic lymphoma kinase in the pathogenesis of cancer.Nat Rev Cancer. 2008; 8: 11-23
- Novel TRAF1-ALK fusion identified by deep RNA sequencing of anaplastic large cell lymphoma.Genes Chromosomes Cancer. 2013; 52: 1097-1102
- STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma.Leukemia. 2021; 35: 1500-1505
- Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target.Haematologica. 2021; 106: 1693-1704
- ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.Blood. 2014; 124: 1473-1480
- Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.Blood. 2011; 117: 915-919
- Double-hit" of DUSP22 and TP63 rearrangements in anaplastic large cell lymphoma, ALK-negative.Blood. 2020; 135: 700
- European T-Cell Lymphoma Study Group, T-Cell Project: Prospective Collection of Data in Patients with Peripheral T-Cell Lymphoma and the AIRC 5xMille Consortium “Genetics-Driven Targeted Management of Lymphoid Malignancies”. Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma.Cancer Cell. 2015; 27: 516-532
- Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts.Blood. 2016; 127: 221-232
- Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma.Blood. 2016; 128: 1234-1245
- JAK2 Rearrangements Are a Recurrent Alteration in CD30+ Systemic T-Cell Lymphomas with Anaplastic Morphology.Am J Surg Pathol. 2021; 45: 895-904
- Recurrent MSCE116Kmutations in ALK-negative anaplastic large cell lymphoma.Blood. 2019; 133: 2776-2789
- musculin: a murine basic helix-loop-helix transcription factor gene expressed in embryonic skeletal muscle.Mech Dev. 1998; 76: 197-201
Article info
Publication history
Published online: September 28, 2022
Identification
Copyright
Published by Elsevier Inc.
